Business Context and Reporting Period
Company: Topspin Medical, Inc. (Note: Input metadata referenced "My Size, Inc.", but the filing text identifies the registrant as Topspin Medical, Inc.)
Reporting Period: Quarter ended March 31, 2011
Status: Development Stage Company; Shell Company; Smaller Reporting Company.
Operations: The Company suspended operational activities in October 2008 due to financial constraints. It has not generated revenue since inception. The Company is currently focused on completing Chapter 11 bankruptcy proceedings and exploring new business avenues or capital raising opportunities.
Key Financial Metrics
| Metric | Value (NIS) | Value (USD Approx.) |
|---|---|---|
| Revenue | 0 | $0 |
| Net Loss (Q1 2011) | (715,000) | ($199,000) |
| Cash and Cash Equivalents | 74,000 | ($21,000) |
| Accumulated Deficit | (185,147,000) | ($51,413,000) |
| Cash Flow from Operations | (186,000) | ($52,000) |
| Cash Flow from Financing | 227,000 | ($63,000) |
| Shares Outstanding | 11,645,405 | N/A |
Material Changes vs. Prior Period
- Net Loss: Decreased slightly to NIS 715,000 ($199,000) from NIS 779,000 ($210,000) in the same period of 2010.
- Operating Cash Flow: Usage decreased significantly to NIS 186,000 ($52,000) from NIS 1,068,000 ($291,000) in Q1 2010, attributed to the completion of Chapter 11 arrangements.
- Financing Cash Flow: Shifted from a usage of NIS 200,000 ($54,000) in Q1 2010 to an inflow of NIS 227,000 ($63,000) in Q1 2011, primarily due to a loan from an interested party.
- General & Administrative Expenses: Decreased to NIS 700,000 ($194,000) from NIS 803,000 ($215,000) in the prior year quarter.
Outlook, Risks, and Management Commentary
- Liquidity Risk: Management states cash resources are insufficient to sustain operations for the next twelve months. The Company is actively seeking new capital and business activities.
- Bankruptcy Proceedings: The Company filed for Chapter 11 relief in July 2010. A reorganization plan was approved by the Bankruptcy Court on December 21, 2010, involving a reverse stock split and conversion of debt to equity.
- Debt Settlement: In February 2011, the Company allocated 10,122,463 shares to Medgenesis as repayment for a debt of approximately $484,000.
- Listing Status: The Company faces potential delisting from the Tel Aviv Stock Exchange (TASE) if it fails to meet minimum equity requirements by June 18, 2012.
- Contingencies: The Company recorded provisional tax liabilities of NIS 1,231,000 ($353,000) related to the conversion of Series A Bonds.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to market volatility and the uncertainty of raising additional funds.
Investor Verification Checklist
- Verify the current status of the Chapter 11 bankruptcy plan implementation and any remaining court approvals required.
- Confirm the Company's ability to raise the capital necessary to avoid insolvency within the next 12 months.
- Review the specific terms of the TASE listing compliance deadline (June 18, 2012) and the Company's plan to meet the NIS 2 million equity requirement.
- Assess the validity and enforceability of the provisional tax liability of NIS 1,231,000.
- Confirm the exact number of shares outstanding post-reverse split and debt conversion as of the most recent date.